Cite
MLA Citation
S.C. Cecere et al.. “D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial.” Annals of oncology, vol. 26, n.d., p. vi33. http://access.bl.uk/ark:/81055/vdc_100097084191.0x00001f